Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,700 shares at $90.07 ($603K) on 2018-09-25, disclosed to the SEC on 2018-09-27.
Open-market sale of $603k RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |